<div class="FTQUOTE"><begin quote><i>Originally posted by: <b>Kristen</b></i> This is so wonderful!!!! I thought they just approved it for G551D? I thought they were doing additional trials for the other gating mutations. I'm curious to hear from those with G551D how the insurance approval process works - will insurance start covering it right away?</end quote>
Other gating mutations are less common in CF and account for <span><1% of mutant alleles. In vitro studies using CF epithelial cell lines show that the gating mutations respond to VX-770 in a similar manner to the G551D mutation in vitro.
Other gating mutations are less common in CF and account for <span><1% of mutant alleles. In vitro studies using CF epithelial cell lines show that the gating mutations respond to VX-770 in a similar manner to the G551D mutation in vitro.